Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
196 hedge funds and large institutions have $2.65B invested in Axonics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 79 increasing their positions, 60 reducing their positions, and 18 closing their positions.
67% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 18
32% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 60
5% more funds holding
Funds holding: 186 → 196 (+10)
7% less capital invested
Capital invested by funds: $2.84B → $2.65B (-$194M)
85% less call options, than puts
Call options by funds: $3.94M | Put options by funds: $26.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$33.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$16.4M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$15.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.7M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$14.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$30.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$28.1M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$27.8M |
| 4 |
PA
Perceptive Advisors
New York
|
-$21.4M |
| 5 |
Jennison Associates
New York
|
-$19.3M |
AXNX Hedge Fund Activity: Q2 2022 in Review
196 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q2 2022, worth a combined $2.65B — down 6.8% from $2.84B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new AXNX positions and 18 closed out — a net gain of 12 holders — while 79 added to existing stakes and 60 trimmed.
The largest buyer was Norges Bank, adding an estimated $33.8M. The largest seller was RTW Investments, cutting an estimated $30.9M.
- 196 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q2 2022, up from 186 in Q1 2022.
- Funds reported $2.65B of Axonics, Inc. Common Stock stock for Q2 2022, down 6.8% quarter-over-quarter.
- 30 funds opened new Axonics, Inc. Common Stock positions in Q2 2022 and 18 closed out, a net change of +12 holders.
- The largest Axonics, Inc. Common Stock buyer in Q2 2022 was Norges Bank, an estimated $33.8M added.
- The largest Axonics, Inc. Common Stock seller in Q2 2022 was RTW Investments, an estimated $30.9M sold.
Based on aggregated 13F filings for Q2 2022.